Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

184.60 +2.77 (+1.52%)
Official Closing Price Updated: 7:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Zoetis

< Previous 1 2 3 Next >
Zoetis Declares First Quarter 2024 Dividend; Board Approves 15% Payment Increase
From Zoetis Inc.
Via Business Wire
Zoetis to Participate in the Piper Sandler 35th Annual Healthcare Conference
From Zoetis Inc.
Via Business Wire
Zoetis Announces Third Quarter 2023 Results
From Zoetis Inc.
Via Business Wire
Zoetis Declares Fourth Quarter 2023 Dividend
From Zoetis Inc.
Via Business Wire
Zoetis Named a 100 Best Company for Working Parents by Seramount
From Zoetis Inc.
Via Business Wire
Zoetis to Host Webcast and Conference Call on Third Quarter 2023 Financial Results
From Zoetis Inc.
Via Business Wire
DMF Group and Corporate Finance Associates acted as the exclusive M&A advisors of adivo
Los Angeles, California 9-16-2023, DMF Group, Frankfurt, and its partner Corporate Finance Associates Worldwide (CFAW), Los Angeles, exclusively advised the shareholders of adivo GmbH, Puchheim near... 
Via PR Leap
Zoetis Foundation Announces $2.6 Million in Grants to Advance Opportunities for Veterinarians and Livestock Farmers
From Zoetis Inc.
Via Business Wire
Zoetis to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Zoetis Inc.
Via Business Wire
Zoetis Welcomes Officials to Celebrate New R&D Building in Durham, N.C.
From Zoetis
Via Business Wire
Media Advisory: Ribbon-cutting Ceremony for new Zoetis facility in Durham, N.C., to expand diagnostics R&D and engineering capabilities and bring more jobs to Durham
From Zoetis Inc.
Via Business Wire
Zoetis Welcomes Officials to Open New State-of-the-Art Facility in Lincoln
From Zoetis
Via Business Wire
Zoetis Announces Second Quarter 2023 Results
From Zoetis Inc.
Via Business Wire
MarketBeat Week in Review – 07/31 - 08/04
A weaker than expected jobs report lifted the market but next week's CPI and PPI reports could change investor sentiment 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Media Advisory: Ribbon Cutting Ceremony for new Zoetis facility in Lincoln, NE, to expand manufacturing capabilities and bring more jobs to Lincoln
From Zoetis Inc.
Via Business Wire
Rising Dividend Make Zoetis a Doggone Winner
Investors that typically focus on other large cap pharmaceutical plays may wish to consider an alternative bet on pets with shares of Zoetis. 
Via MarketBeat
Zoetis Named One of the Best Workplaces for Innovators by Fast Company
From Zoetis Inc.
Via Business Wire
Zoetis Announces Appointment of Ester Banque as President of U.S. Operations for World Leader in Animal Health
From Zoetis Inc.
Via Business Wire
Zoetis to Host Webcast and Conference Call on Second Quarter 2023 Financial Results
From Zoetis Inc.
Via Business Wire
PetVivo Sales Spryng Higher on Injectable OA Relief for Pets
Developmental biomedical device company PetVivo Holdings Inc. (NASDAQ: PETV) makes pet medical devices and therapeutics. What kind of medical devices would 
Via MarketBeat
Bullish or Bearish? Vetting Animal Health Care Stocks
Americans are paying more and more attention to pet health, making pet care stocks look healthy again. Here are two names worth a check up. 
Via MarketBeat
Topics ETFs
Zoetis Releases 2022 Sustainability Report to Share Progress in Building a Better Future for People, Animals and the Planet
From Zoetis Inc.
Via Business Wire
Zoetis to Participate in the Stifel 2023 Jaws and Paws Conference
From Zoetis Inc.
Via Business Wire
Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade
From Zoetis Inc.
Via Business Wire
Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally 
Via MarketBeat
Zoetis Declares Third Quarter 2023 Dividend
From Zoetis Inc.
Via Business Wire
Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs
From Zoetis Inc.
Via Business Wire
Zoetis Announces First Quarter 2023 Results
From Zoetis Inc.
Via Business Wire
Zoetis Announces Date for 2023 Investor Day
From Zoetis Inc.
Via Business Wire
Zoetis Foundation Announces First Round of 2023 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Well-being
From Zoetis Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.